{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T07:09:27Z","timestamp":1648624167651},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.remn.2016.09.003","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T17:46:52Z","timestamp":1477417612000},"page":"103-109","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Additional value of hybrid SPECT\/CT systems in neuroendocrine tumors, adrenal tumors, pheochromocytomas and paragangliomas"],"prefix":"10.1016","volume":"36","author":[{"given":"K.K.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Chondrogiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.","family":"Marzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Giammarile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Colletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2016.09.003_bib0005","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1007\/s00261-015-0524-7","article-title":"Pancreatic neuroendocrine tumors: correlation between histogram analysis of apparent diffusion coefficient maps and tumor grade","volume":"40","author":"Pereira","year":"2015","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.remn.2016.09.003_bib0010","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0b013e3181ec124e","article-title":"The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems","volume":"39","author":"Klimstra","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.remn.2016.09.003_bib0015","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/MPA.0b013e3181ebaffd","article-title":"NANETS consensus guidelines for the diagnosis of neuroendocrine tumor","volume":"39","author":"Vinik","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.remn.2016.09.003_bib0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11102-006-0269-y","article-title":"Functional imaging of neuroendocrine tumours with PET","volume":"9","author":"Mottaghy","year":"2006","journal-title":"Pituitary"},{"key":"10.1016\/j.remn.2016.09.003_bib0025","first-page":"150","article-title":"Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors","volume":"48","author":"Bombardieri","year":"2004","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.09.003_bib0030","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s00330-004-2590-z","article-title":"Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours","volume":"15","author":"Amthauer","year":"2005","journal-title":"Eur Radiol"},{"key":"10.1016\/j.remn.2016.09.003_bib0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12149-010-0383-9","article-title":"SPECT\/CT stabilizes the interpretation of somatostatin receptor scintigraphy findings: a retrospective analysis of inter-rater agreement","volume":"24","author":"Apostolova","year":"2010","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0040","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s11547-008-0319-9","article-title":"Impact of 111In-DTPA-octreotide SPECT\/CT fusion images in the management of neuroendocrine tumours","volume":"113","author":"Castaldi","year":"2008","journal-title":"Radiol Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0045","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s00259-005-1875-z","article-title":"Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours","volume":"32","author":"Gabriel","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.09.003_bib0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.crad.2006.04.001","article-title":"The clinical impact of a combined gamma camera\/CT imaging system on somatostatin receptor imaging of neuroendocrine tumours","volume":"61","author":"Hillel","year":"2006","journal-title":"Clin Radiol"},{"key":"10.1016\/j.remn.2016.09.003_bib0055","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.rlu.0000242599.22310.d2","article-title":"Endocrine neoplasm scintigraphy: added value of fusing SPECT\/CT images compared with traditional side-by-side analysis","volume":"31","author":"Ingui","year":"2006","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0060","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2265.2003.01885.x","article-title":"SPECT\/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours","volume":"59","author":"Krausz","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.remn.2016.09.003_bib0065","first-page":"323","article-title":"Octreo-SPECT\/CT imaging for accurate detection and localization of suspected neuroendocrine tumors","volume":"52","author":"Perri","year":"2008","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.09.003_bib0070","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00259-003-1160-y","article-title":"Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms","volume":"30","author":"Pfannenberg","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.09.003_bib0075","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.mnm.0000243372.26507.e7","article-title":"SPECT\/CT imaging using a spiral CT scanner for anatomical localization: impact on diagnostic accuracy and reporter confidence in clinical practice","volume":"27","author":"Roach","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.remn.2016.09.003_bib0080","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/MNM.0b013e3282efa1a9","article-title":"Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT","volume":"28","author":"Ruf","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.remn.2016.09.003_bib0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MNM.0b013e32834cecfe","article-title":"Specificity and sensitivity of (9)(9)mTc-EDDA\/HYNIC-Tyr(3)-octreotide ((9)(9)mTc-TOC) for imaging neuroendocrine tumors","volume":"33","author":"Sepulveda-Mendez","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.remn.2016.09.003_bib0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.acra.2009.08.015","article-title":"Incremental value of 111-In pentetreotide SPECT\/CT fusion imaging of neuroendocrine tumors","volume":"17","author":"Wong","year":"2010","journal-title":"Acad Radiol"},{"key":"10.1016\/j.remn.2016.09.003_bib0095","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1097\/RLU.0000000000001112","article-title":"Molecular imaging in the management of adrenocortical cancer: a systematic review","volume":"41","author":"Wong","year":"2016","journal-title":"Clin Nucl Med."},{"key":"10.1016\/j.remn.2016.09.003_bib0100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MNM.0000000000000239","article-title":"Contribution of 111In-pentetreotide SPECT\/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours","volume":"36","author":"Sainz-Esteban","year":"2014","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.remn.2016.09.003_bib0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/RLU.0b013e3181feedc0","article-title":"Comparison of single time-point [111-In] pentetreotide SPECT\/CT with dual time-point imaging of neuroendocrine tumors","volume":"36","author":"Wong","year":"2011","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4274\/Mirt.68552","article-title":"The diagnostic efficiency of 99mTc-EDDA\/HYNIC-octreotate SPECT-CT in comparison with 111In-pentetrotide in the detection of neuroendocrine tumours","volume":"22","author":"Kocyigit Deveci","year":"2013","journal-title":"Mol Imaging Radionucl Ther"},{"key":"10.1016\/j.remn.2016.09.003_bib0115","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2478\/raon-2014-0018","article-title":"Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: evaluation of Ga-68 DOTATOC PET\/CT and In-111 DTPA octreotide SPECT\/CT","volume":"48","author":"Schreiter","year":"2014","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.remn.2016.09.003_bib0120","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2967\/jnumed.114.144543","article-title":"68Ga-DOTATATE PET\/CT, 99mTc-HYNIC-octreotide SPECT\/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial","volume":"55","author":"Etchebehere","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0125","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s12149-014-0900-3","article-title":"Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumors","volume":"28","author":"Kubota","year":"2014","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0130","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.2967\/jnumed.111.088203","article-title":"Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors","volume":"52","author":"Grimes","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2967\/jnumed.112.107524","article-title":"Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment","volume":"54","author":"Sandstrom","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0140","doi-asserted-by":"crossref","first-page":"112503","DOI":"10.1118\/1.4824318","article-title":"An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT\/CT imaging","volume":"40","author":"Jackson","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.remn.2016.09.003_bib0145","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00259-013-2504-x","article-title":"Rapid blood clearance and lack of long-term renal toxicity of 177Lu-DOTATATE enables shortening of renoprotective amino acid infusion","volume":"40","author":"Kashyap","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.09.003_bib0150","first-page":"1038","article-title":"A new and superior adrenal scanning agent, NP-59","volume":"16","author":"Sarkar","year":"1975","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0155","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.surg.2008.07.025","article-title":"The role of radiologic studies in the evaluation and management of primary hyperaldosteronism","volume":"144","author":"White","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.remn.2016.09.003_bib0160","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"Kloos","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.remn.2016.09.003_bib0165","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/145749690809700308","article-title":"The role of adrenal scintigraphy in the preoperative management of primary aldosteronism","volume":"97","author":"Volpe","year":"2008","journal-title":"Scand J Surg"},{"key":"10.1016\/j.remn.2016.09.003_bib0170","first-page":"526","article-title":"Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging","volume":"31","author":"Kazerooni","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0175","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/RLU.0b013e3181f4a16d","article-title":"Adrenal cortical imaging with I-131 NP-59 SPECT-CT","volume":"35","author":"Wong","year":"2010","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0180","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00259-014-2692-z","article-title":"Prognostic value of semiquantification NP-59 SPECT\/CT in primary aldosteronism patients after adrenalectomy","volume":"41","author":"Lu","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.09.003_bib0185","doi-asserted-by":"crossref","first-page":"317934","DOI":"10.1155\/2013\/317934","article-title":"NP-59 SPECT\/CT imaging in stage 1 hypertensive and atypical primary aldosteronism: a 5-year retrospective analysis of clinicolaboratory and imaging features","volume":"2013","author":"Chen","year":"2013","journal-title":"Sci World J"},{"key":"10.1016\/j.remn.2016.09.003_bib0190","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1210\/jc.2008-0050","article-title":"[123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes","volume":"93","author":"Hahner","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.remn.2016.09.003_bib0195","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12672-011-0093-3","article-title":"Metomidate-based imaging of adrenal masses","volume":"2","author":"Hahner","year":"2011","journal-title":"Horm Cancer"},{"key":"10.1016\/j.remn.2016.09.003_bib0200","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1210\/jc.2011-2765","article-title":"[131I]iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinoma","volume":"97","author":"Hahner","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 1","key":"10.1016\/j.remn.2016.09.003_bib0205","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.nucmedbio.2008.04.007","article-title":"A clinical overview of pheochromocytomas\/paragangliomas and carcinoid tumors","volume":"35","author":"Ilias","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.remn.2016.09.003_bib0210","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1210\/er.2003-0032","article-title":"Functional imaging of endocrine tumors: role of positron emission tomography","volume":"25","author":"Pacak","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.remn.2016.09.003_bib0215","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jc.2009-2604","article-title":"123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis","volume":"95","author":"Jacobson","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.remn.2016.09.003_bib0220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/0972-3919.108877","article-title":"Iodine-131 meta-iodobezylguanidine single photon emission computed tomography\/computerized tomography in diagnosis of neuro-endocrine tumors","volume":"27","author":"Harisankar","year":"2012","journal-title":"Indian J Nucl Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RLU.0b013e3181feeb5e","article-title":"Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT\/CT over planar image in patients with malignant pheochromocytoma\/paraganglioma and neuroblastoma","volume":"36","author":"Fukuoka","year":"2011","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0230","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2214\/AJR.07.2107","article-title":"Added value of SPECT\/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma","volume":"190","author":"Rozovsky","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.remn.2016.09.003_bib0235","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1245\/s10434-009-0850-5","article-title":"The utility of metaiodobenzylguanidine single photon emission computed tomography\/computed tomography (MIBG SPECT\/CT) for the diagnosis of pheochromocytoma","volume":"17","author":"Meyer-Rochow","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.remn.2016.09.003_bib0240","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1097\/RLU.0b013e318279bcb2","article-title":"Can hybrid SPECT-CT overcome the limitations associated with poor imaging properties of 131I-MIBG? Comparison with planar scintigraphy and SPECT in pheochromocytoma","volume":"38","author":"Sharma","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0245","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/RLU.0b013e318263923d","article-title":"Intraindividual comparison of 123I-mIBG SPECT\/MRI, 123I-mIBG SPECT\/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines","volume":"38","author":"Derlin","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.remn.2016.09.003_bib0250","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00259-010-1720-x","article-title":"Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine","volume":"38","author":"Kroiss","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.09.003_bib0255","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00259-014-2892-6","article-title":"(68)Ga-DOTATOC PET\/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to (123)I-MIBG SPECT\/CT","volume":"42","author":"Kroiss","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.09.003_bib0260","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/MNM.0b013e328342823d","article-title":"First experiences from Copenhagen with paediatric single photon emission computed tomography\/computed tomography","volume":"32","author":"Andersen","year":"2011","journal-title":"Nucl Med Commun"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X16300865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X16300865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T03:55:34Z","timestamp":1536292534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X16300865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2253654X16300865"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2016.09.003","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Additional value of hybrid SPECT\/CT systems in neuroendocrine tumors, adrenal tumors, pheochromocytomas and paragangliomas","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2016.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. y SEMNIM. All rights reserved.","name":"copyright","label":"Copyright"}]}}